Divergent and convergent evolution in metastases suggest treatment strategies based on specific metastatic sites
Author(s) -
Jessica J. Cunningham,
Joel S. Brown,
T. L. Vincent,
Robert A. Gatenby
Publication year - 2015
Publication title -
evolution medicine and public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 22
ISSN - 2050-6201
DOI - 10.1093/emph/eov006
Subject(s) - divergence (linguistics) , metastatic tumor , metastasis , systemic therapy , primary tumor , cancer , medicine , molecular evolution , targeted therapy , oncology , evolutionary biology , biology , gene , phylogenetics , genetics , philosophy , linguistics , breast cancer
Systemic therapy for metastatic cancer is currently determined exclusively by the site of tumor origin. Yet, there is increasing evidence that the molecular characteristics of metastases significantly differ from the primary tumor. We define the evolutionary dynamics of metastases that govern this molecular divergence and examine their potential contribution to variations in response to targeted therapies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom